Merseyside Local Peer Support Group
Saturday 12 October, 1.00pm - 2.00pm *Rescheduled from 5 October* In-person Wellbeing Event - Come and join us for a session of Puppy Yoga!
Search results
Saturday 12 October, 1.00pm - 2.00pm *Rescheduled from 5 October* In-person Wellbeing Event - Come and join us for a session of Puppy Yoga!
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
Inflammation and retinal degeneration in retinitis pigmentosa: Can lessons learned in the lab help us identify treatments in the clinic?
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.
Our Keynote speaker will be Mr Kanmin Xue. Mr Xue is a Consultant Vitreo-retinal Surgeon at the John Radcliffe Hospital and Wellcome Trust clinician scientist fellow at the University of Oxford where he leads the Retinal Disease and Repair Group.
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Many of our materials can be downloaded from our website, free of charge. Printed materials can be ordered as well.
As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected families can access a genetic diagnosis, potentially opening up choices around treatment and clinical trial participation.
Funding from Retina UK has allowed to team to explore the viability of gene therapy as a treatment for RP and related conditions, and build a pipeline of clinical trials.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.